Pulse Biosciences (PLSE) Payables (2015 - 2025)

Pulse Biosciences' Payables history runs 11 years deep, the most recent figure standing at $2.8 million for Q4 2025.

• In Q4 2025, Payables rose 65.99% year-over-year to $2.8 million; the TTM figure through Dec 2025 stood at $2.8 million (up 65.99% YoY), while the FY2025 annual figure was $2.8 million, up 65.99% from the prior year.
• Payables was $2.8 million for Q4 2025 at Pulse Biosciences, down from $3.0 million in the prior quarter.
• In the past five years, Payables ranged from a high of $4.6 million in Q2 2021 to a low of $1.4 million in Q3 2023.
• Historically, Payables has averaged $2.4 million across 5 years, with a median of $2.3 million in 2021.
• The sharpest annual moves came in 2021 and 2022: Payables surged 205.78% in 2021, then plunged 57.22% in 2022.
• A 5-year view of Payables shows it stood at $2.3 million in 2021, then advanced by 9.6% to $2.5 million in 2022, then retreated by 26.27% to $1.8 million in 2023, then decreased by 8.88% to $1.7 million in 2024, then jumped by 65.99% to $2.8 million in 2025.
• The last three Payables figures came in at $2.8 million (Q4 2025), $3.0 million (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.